Search
Now showing items 1-1 of 1
Adjunctive therapies to reduce thrombotic events in patients with a history of myocardial infarction : role of vorapaxar
(2015-07-22)
Acute myocardial infarction (AMI) is generally attributed to coronary atherothrombotic disease. Platelet activation is essential for thrombus formation and is thus an important target for pharmacological intervention to ...